KAS
VYGR icon

Kestra Advisory Services’s Voyager Therapeutics VYGR Stock Holding History

Kestra Advisory Services’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-49,207
Closed -$279K – 2909
2024
Q4 		$279K Sell
49,207
-38,375
-44% -$247K ﹤0.01% 2279
2024
Q3 		$512K Sell
87,582
-153,937
-64% -$1.12M ﹤0.01% 1753
2024
Q2 		$1.91M Sell
241,519
-14,930
-6% -$125K 0.01% 978
2024
Q1 		$2.39M Buy
256,449
+40,368
+19% +$341K 0.02% 798
2023
Q4 		$1.82M Buy
216,081
+89,598
+71% +$650K 0.01% 832
2023
Q3 		$980K Buy
+126,483
New +$1.15M 0.01% 1007

Other funds holding VYGR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kestra Advisory Services's VYGR Position: Q1 2025 in Review

Kestra Advisory Services sold out of Voyager Therapeutics (VYGR) in Q1 2025, closing a stake of 49,207 shares — an estimated $279K sold.

Kestra Advisory Services first reported a position in VYGR in Q3 2023 and held it in 6 quarters. The position peaked at $2.39M in Q1 2024. 116 funds tracked by Wall St. Rank hold VYGR as of Q1 2025.

  • Kestra Advisory Services reported no remaining Voyager Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Kestra Advisory Services sold 49,207 Voyager Therapeutics shares in Q1 2025, an estimated $279K.
  • Kestra Advisory Services first reported a position in Voyager Therapeutics in Q3 2023 and held it in 6 quarters.
  • Kestra Advisory Services's Voyager Therapeutics position peaked at $2.39M in Q1 2024.
  • 116 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2025.

Based on Kestra Advisory Services's 13F filing for Q1 2025, filed 14 May 2025.